Clinical trials are an important way to improve treatment for people with cancer. While most are continuing during the COVID-19 pandemic, the period of time that clinical trials are available and recruiting may change quickly. If you would like to get involved in a clinical trial, speak to your treatment team or the health service where the clinical trial is being undertaken, to confirm it is open and appropriate for you. For cancer information and support, call Cancer Council's experienced cancer nurses on 13 11 20 Monday to Friday from 9am-5pm.

EX-TEM : Phase III Trial of Extended Temozolomide in Newly Diagnosed Glioblastoma

Male or<br/>FemaleGender Male or
Female

RecruitingStatus Recruiting

Systemic<br/>Therapy TrialTypeSystemic
Therapy Trial

ThreePhase Three

18+Age Over 18

Brain and Spinal<br/>CancersCancer LocationBrain and Spinal
Cancers

Systemic therapy | Brain and spinal cordAstrocytoma,Brain,Glioblastoma (GBM)

Trial Overview Read MoreRead more

This phase III trial is trying to determine if extended post-radiation chemotherapy will improve survival outcomes in patients with newly diagnosed glioblastoma.
 

This trial is treating patients with glioblastoma.

This is a systemic therapy trial.

You may be able to join this trial if:

  • You have had a certain type of treatment or surgical procedure.
  • Your cancer has not spread to other parts of the body.

You may be excluded from this trial if:

  • You have a certain disease or psychological condition.
  • You have been diagnosed with a prior or secondary type of cancer.
  • You have had certain treatments, surgical procedures or drugs.

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

Clinical Summary Read MoreRead more

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Scientific Title

Phase III Trial of Extended Temozolomide in Newly Diagnosed Glioblastoma

Other Non-Commercial Sponsor

Walter and Eliza Hall Institute

Summary

This trial is comparing two standards of care - 6 versus 12 cycles of post radiation temozolomide. Patients in Arm A of the trial will undergo observation with standard clinical and radiological follow up. Patients in Arm B will receive an additional 6 cycles of post-radiation temozolomide (orally) followed by observation with standard clinical and radiological follow up.

Recruiting Hospitals Read MoreRead more

Alfred Hospital, Medical Oncology
Prahran
Ms Kate Sinn
K.Sinn@alfred.org.au
03 90760569

Ballarat Hospital
Ballarat
Ms Carmel Goss
CarmelG@bhs.org.au
03 5320 4735

Bendigo Hospital
Bendigo
Ms Felicity Osmond

03 5454 8821

Epworth Hospital
Richmond
Ms Jenni Flynn
jenni.flynn@epworth.org.au
03 9936 8206

Epworth Freemasons, Medical Oncology
East Melbourne
Ms Jenni Flynn
jenni.flynn@epworth.org.au
03 9936 8206

Monash Health, Medical Oncology
Clayton
Genitourinary Research Study Coordinator
gu.oncresearch@monashhealth.org
0436387664

St Vincent's Hospital, Medical and Radiation Oncology
Fitzroy
Ms Nadia Ranieri
oncology.research@svha.org.au
03 9231 3167

South West Healthcare
Warrnambool
Kaye McDowall
swhct@swh.net.au

Not Recruiting Hospitals Read MoreRead more

Closed

PCCTU (Parkville Cancer Clinical Trials Unit) *
Parkville
Enquiries Line Coordinator
clinicaltrials.enquiries@petermac.org
03 8559 7456 (9am-2pm, Mon-Fri)

Trial Overview: General information about a clinical trial. This section provides an overview of who might be able to join this trial and what type of treatment is involved.

Next